fascaplysine has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, W; He, M; Jin, H; Li, Y; Liang, H; Liang, W; Lin, M; Liu, F; Mou, C; Pan, H; Qiu, H; Wang, H; Xiao, X; Yan, X; Yang, M; Zhang, D; Zhang, K; Zhang, P | 1 |
| Cui, W; He, S; Liang, H; Lin, M; Liu, F; Ma, J; Naman, CB; Sang, J; Sun, Q; Wang, N; Xiao, X; Yan, S; Yan, X | 1 |
2 other study(ies) available for fascaplysine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Fascaplysin Derivatives Are Potent Multitarget Agents against Alzheimer's Disease:
Topics: Alzheimer Disease; Animals; Blood-Brain Barrier; Cell Line, Tumor; Drug Delivery Systems; Humans; Indoles; Male; Maze Learning; Mice; Mice, Inbred ICR; Protein Structure, Secondary | 2019 |
9-Methylfascaplysin Is a More Potent Aβ Aggregation Inhibitor than the Marine-Derived Alkaloid, Fascaplysin, and Produces Nanomolar Neuroprotective Effects in SH-SY5Y Cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cell Survival; Humans; Hydrogen Bonding; Indoles; Models, Molecular; Molecular Dynamics Simulation; Neurons; Neuroprotective Agents | 2019 |